Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

Publisher DOI
PubMed ID
20980427
Description
The expression of vascular endothelial growth factor (VEGF) is elevated in diabetic macular edema (DME). Ranibizumab binds to and inhibits multiple VEGF variants. We investigated the safety and efficacy of ranibizumab in DME involving the foveal center.
Date of Publication
2010
Publication Type
Article
Language(s)
en
Contributor(s)
Massin, Pascale
Bandello, Francesco
Garweg, Justus G
Hansen, Lutz L
Harding, Simon P
Larsen, Michael
Mitchell, Paul
Sharp, Dianne
Gekkieva, Margarita
Weichselberger, Andreas
Additional Credits
Series
Diabetes care
Publisher
American Diabetes Association
ISSN
0149-5992
Access(Rights)
metadata.only
Show full item